BioCer’s primary scope is the development and production of plant based haemostatic materials, in order to assist medical professionals in the control of blood loss in a diverse range of complex surgical procedures. BioCer has also commercialized a unique advanced surface coating system made of titanium oxide, in order to improve the biocompatibility of surgical meshes for application in hernia repair and breast reconstruction.
NEW: HameoCer™ PLUS reduces postoperative adhesions
Latest Development: HaemoCer™ Endoscopic Applicator
Bavarian Export Award 2019: Winner in the category industry
BioCer Entwicklungs-GmbH is a young and innovative medical device company from Bayreuth, Bavaria. Learn more >
TiO2Mesh™ is a surgical mesh implant which utilizes a biocompatible titanium coated material surface, this breakthrough offers superior biocompatibility and advanced performance. Learn more >
Would you like to visit us at a trade fair? All trade fair dates can be found here: Learn more >
BioCer supports the Evang. Kita Birken (Diakonie Bayreuth). Learn More >
BioCer Entwicklungs-GmbH
BioCer Entwicklungs-GmbH is a young and innovative medical device company located in Bayreuth, Bavaria. We are specialized in research, development and production of innovative medical biomaterial products without animal or human components. Being a service provider, we offer innovative coating systems for existing implant systems and also develop new medical products for our customers.
BioCer Entwicklungs-GmbH commercializes innovative technologies developed in conjunction with leading national and international universities.